Tenofovir (Viread): Research
- Tenofovir Appears Effective Against HIV and Hepatitis B in Coinfected People (June 12, 2007)
From aidsmap.com
- Link Between Tenofovir and Renal Toxicity Remains Tenuous, but Monitoring Is Warranted (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
On TheBodyPRO.com
- HIV JournalView: Tenofovir + Didanosine: The Downfall of a Lovely Combination (January 2006)
Part of David Wohl, M.D.'s review of the top 10 HIV research reports of 2005.
In HIV JournalView, from TheBodyPRO.com
- HIV JournalView: Risk of Tenofovir Nephrotoxicity May Be Real, Though Murky (January 2006)
Part of David Wohl, M.D.'s review of the top 10 HIV research reports of 2005.
In HIV JournalView, from TheBodyPRO.com
- Researchers Uncover Possible Alternative Pathway to Tenofovir Resistance (December 17, 2005)
In The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy
On TheBodyPRO.com
- Drugs to Reverse Lipoatrophy Show So-So Effects (December 16, 2005)
In The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy
On TheBodyPRO.com
- Tenofovir Proves Safe for Kidneys After Three Years of Use (December 16, 2005)
In The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy
On TheBodyPRO.com
- Spanish Study Finds Association Between Long-Term Treatment With Tenofovir and Kidney Toxicity Still Unclear (December 16, 2005)
In The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy
On TheBodyPRO.com
- Quad Nucleoside/tide Regimen of Trizivir + Tenofovir Effective, Well Tolerated as Second-Line Therapy (July 27, 2005)
In The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment
On TheBodyPRO.com
- Once-Daily Abacavir + Lamivudine + Tenofovir Fails in Naive Patients (April 2005)
In Expert Opinion on Investigational Drugs, from TheBodyPRO.com
- Sequencing and 2 of the Most Popular Backbone Regimens (February 25, 2005)
A comparison of resistance mutations with abacavir + lamivudine versus tenofovir + lamivudine.
In The 12th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus (HBV) (January 2005)
In Infectious Diseases in Corrections Report, from Brown Medical School
- Tenofovir and Efavirenz Show Promise as Two-Drug Maintenance Regimen (July 26, 2004)
The so-called "COOL Study" examined this novel two-drug regimen in patients who had already achieved viral suppression on traditional, three-drug HAART.
From aidsmap.com
- Substituting With Tenofovir Decreases the Adverse Effects Seen With Other NRTIs (July 14, 2004)
In The XV International AIDS Conference, from TheBodyPRO.com
- Update on Long-Term Follow-Up Studies on Tenofovir (July 14, 2004)
In The XV International AIDS Conference, from TheBodyPRO.com
- Tenofovir and Abacavir Do Not Interact in Patients on Triple-Nucleoside Regimens (July 13, 2004)
In The XV International AIDS Conference, from TheBodyPRO.com
- Failure of Tenofovir/Abacavir/Lamivudine Combination Still Unexplained (July 13, 2004)
In The XV International AIDS Conference, from TheBodyPRO.com
- Lamivudine/Abacavir Is an Effective Nucleoside Backbone in Combinations Other Than With Tenofovir (July 13, 2004)
Results suggest that the K65R mutation is behind the failure of this three-drug combination.
In The XV International AIDS Conference, from TheBodyPRO.com
- Both Tenofovir and Stavudine Well Tolerated in HCV-Coinfected Patients (July 12, 2004)
In The XV International AIDS Conference, from TheBodyPRO.com
- High Rate of Virologic Failure With Once-Daily ddI/3TC/TDF (November 2003)
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- On the Lookout for Kidney Problems With Viread (October 2003)
In HIV Treatment ALERTS!, from The Center for AIDS
|
Advertisement
|
Email
Glossary
